ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting.

D Neil Hayes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.